Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

US Post-Market Surveillance Study of the Surfacer System

ClinicalTrials.gov ID: NCT05050799

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05050799. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 8:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

US Post-Market Surveillance Study of the Surfacer* Inside-Out* Access Catheter System (Surfacer System)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Single arm, observational, multi-center, consecutively enrolling, post-market surveillance study. Treating patients in need of central venous access who have upper body venous occlusions or other conditions that preclude central venous access by conventional methods, and who meet the requirements described in the device labeling.

Study identification

NCT ID
NCT05050799
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Merit Medical Systems, Inc.
Industry
Enrollment
30 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 8, 2022 (Actual)
Primary completion
Aug 31, 2027 (Estimated)
Completion
Aug 31, 2027 (Estimated)
Last update posted
Nov 4, 2026

2022 – 2027

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Pima Heart and Vascular Tucson Arizona 85704 Completed
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 Recruiting
Sarasota Memorial Health Care System Sarasota Florida 34239 Recruiting
Emory University Hospital Atlanta Georgia 30322 Recruiting
Ohio State University Hospital Columbus Ohio 43210 Recruiting
Baylor Scott & White Heart and Vascular Hospital Dallas Texas 75226 Recruiting
The University of Texas Health Science Center at Houston Houston Texas 77030 Recruiting
Flow Vascular Institute Pasadena Texas 77504 Completed
St. Mark's Hospital Millcreek Utah 84124 Recruiting
Sentara Norfolk General Hospital Norfolk Virginia 23507 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05050799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.